These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36625973)

  • 21. 3-T MR neurography of lumbo-sacral plexus in hereditary transthyretin-related amyloidosis with polyneuropathy.
    Hodel J; Benadjaoud S; Benadjaoud MA; Lefaucheur JP; Planté-Bordeneuve V
    Eur Radiol; 2022 Nov; 32(11):7865-7871. PubMed ID: 35438324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chance or challenge, spoilt for choice? New recommendations on diagnostic and therapeutic considerations in hereditary transthyretin amyloidosis with polyneuropathy: the German/Austrian position and review of the literature.
    Dohrn MF; Auer-Grumbach M; Baron R; Birklein F; Escolano-Lozano F; Geber C; Grether N; Hagenacker T; Hund E; Sachau J; Schilling M; Schmidt J; Schulte-Mattler W; Sommer C; Weiler M; Wunderlich G; Hahn K
    J Neurol; 2021 Oct; 268(10):3610-3625. PubMed ID: 32500375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late-onset hereditary ATTR V30M amyloidosis with polyneuropathy: Characterization of Brazilian subjects from the THAOS registry.
    Pinto MV; Pinto LF; Dias M; Rosa RS; Mundayat R; Pedrosa RC; Waddington-Cruz M
    J Neurol Sci; 2019 Aug; 403():1-6. PubMed ID: 31163298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic screening for hereditary transthyretin amyloidosis with polyneuropathy in western Sicily: Two years of experience in a neurological clinic.
    Di Stefano V; Lupica A; Alonge P; Pignolo A; Augello SM; Gentile F; Gagliardo A; Giglia F; Brinch D; Cappello M; Di Lisi D; Novo G; Borgione E; Scuderi C; Brighina F
    Eur J Neurol; 2024 Jan; 31(1):e16065. PubMed ID: 37725003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered gut microbiota in Taiwanese A97S predominant transthyretin amyloidosis with polyneuropathy.
    Chen CC; Tseng PH; Hsueh HW; Chiang MC; Tzeng SR; Chiang TH; Wu MS; Hsieh ST; Chao CC
    Sci Rep; 2024 Mar; 14(1):6195. PubMed ID: 38486098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corneal confocal microscopy identifies corneal nerve loss and increased Langerhans cells in presymptomatic carriers and patients with hereditary transthyretin amyloidosis.
    Thimm A; Carpinteiro A; Oubari S; Papathanasiou M; Kessler L; Rischpler C; Malik RA; Herrmann K; Reinhardt HC; Rassaf T; Kleinschnitz C; Hagenacker T; Stettner M
    J Neurol; 2023 Jul; 270(7):3483-3491. PubMed ID: 37014422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of Drugs for ATTRv Amyloidosis in the Real World: How Therapy Is Changing Survival in a Non-Endemic Area.
    Russo M; Gentile L; Di Stefano V; Di Bella G; Minutoli F; Toscano A; Brighina F; Vita G; Mazzeo A
    Brain Sci; 2021 Apr; 11(5):. PubMed ID: 33925301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Normal cardiovascular reflex testing in patients with parkin disease.
    Del Sorbo F; Elia AE; De Joanna G; Romito LM; Garavaglia B; Albanese A
    Mov Disord; 2007 Mar; 22(4):528-32. PubMed ID: 17230469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual-Echo Turbo Spin Echo and 12-Echo Multi Spin Echo Sequences as Equivalent Techniques for Obtaining T2-Relaxometry Data: Application in Symptomatic and Asymptomatic Hereditary Transthyretin Amyloidosis as a Surrogate Disease.
    Poncelet A; Weiler M; Hegenbart U; Sam G; Schönland S; Purrucker JC; Hayes JM; Hund E; Bendszus M; Heiland S; Kollmer J
    Invest Radiol; 2022 May; 57(5):301-307. PubMed ID: 34839307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of patients with autonomic dysfunction in the Transthyretin Amyloidosis Outcomes Survey (THAOS).
    Barroso FA; Coelho T; Dispenzieri A; Conceição I; Waddington-Cruz M; Wixner J; Maurer MS; Rapezzi C; Planté-Bordeneuve V; Kristen AV; González-Duarte A; Chapman D; Stewart M; Amass L;
    Amyloid; 2022 Sep; 29(3):175-183. PubMed ID: 35451899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropathic pain experience in symptomatic and presymptomatic subjects carrying a transthyretin gene mutation.
    Tozza S; Luigetti M; Antonini G; Mazzeo A; Severi D; Di Paolantonio A; Leonardi L; Russo M; Romano A; Forcina F; Gentile L; Nolano M; Mattia C; Manganelli F
    Front Neurol; 2023; 14():1109782. PubMed ID: 36846120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skin amyloid deposits and nerve fiber loss as markers of neuropathy onset and progression in hereditary transthyretin amyloidosis.
    Leonardi L; Adam C; Beaudonnet G; Beauvais D; Cauquil C; Not A; Morassi O; Benmalek A; Trassard O; Echaniz-Laguna A; Adams D; Labeyrie C
    Eur J Neurol; 2022 May; 29(5):1477-1487. PubMed ID: 35100482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multi-Domain Assessment of Autonomic Function in Spinal Cord Injury Using a Modified Autonomic Reflex Screen.
    Berger MJ; Kimpinski K; Currie KD; Nouraei H; Sadeghi M; Krassioukov AV
    J Neurotrauma; 2017 Sep; 34(18):2624-2633. PubMed ID: 28537464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strategies to improve the quality of life in patients with hereditary transthyretin amyloidosis (hATTR) and autonomic neuropathy.
    Gendre T; Planté-Bordeneuve V
    Clin Auton Res; 2019 Sep; 29(Suppl 1):25-31. PubMed ID: 31506870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ala97Ser transthyretin amyloidosis-associated polyneuropathy, clinical and neurophysiological profiles in a Thai cohort.
    Pasutharnchat N; Taychargumpoo C; Vorasettakarnkij Y; Amornvit J
    BMC Neurol; 2021 May; 21(1):206. PubMed ID: 34022837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disease-Modifying Drugs Extend Survival in Hereditary Transthyretin Amyloid Polyneuropathy.
    Ueda M; Misumi Y; Nomura T; Tasaki M; Yamakawa S; Obayashi K; Yamashita T; Ando Y
    Ann Neurol; 2024 Feb; 95(2):230-236. PubMed ID: 38053464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis.
    Carroll A; Dyck PJ; de Carvalho M; Kennerson M; Reilly MM; Kiernan MC; Vucic S
    J Neurol Neurosurg Psychiatry; 2022 Jun; 93(6):668-678. PubMed ID: 35256455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Practice of Hereditary ATTR Amyloidosis in Non-endemic Areas of Japan.
    Matsushima M; Tarisawa M; Nomura T; Oshima Y; Yoshino M; Shibata Y; Wakita M; Shirai S; Iwata I; Yaguchi H; Yabe I
    Intern Med; 2023 Jun; 62(11):1599-1602. PubMed ID: 36261369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progressive brachial plexus enlargement in hereditary transthyretin amyloidosis.
    Salvalaggio A; Coraci D; Obici L; Cacciavillani M; Luigetti M; Mazzeo A; Pastorelli F; Grandis M; Cavallaro T; Bisogni G; Lozza A; Gemelli C; Gentile L; Russo M; Ermani M; Fabrizi GM; Plasmati R; De Napoli F; Campagnolo M; Castellani F; Salvi F; Fenu S; Devigili G; Pareyson D; Gasparotti R; Rapezzi C; Martinoli C; Padua L; Briani C
    J Neurol; 2022 Apr; 269(4):1905-1912. PubMed ID: 34410494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Red flags and adjusted suspicion index for distinguishing hereditary transthyretin amyloid polyneuropathy from idiopathic axonal polyneuropathy.
    Warendorf JK; van der Star GM; Dooijes D; Notermans NC; Vrancken AFJE
    Neurol Sci; 2023 Oct; 44(10):3679-3685. PubMed ID: 37266816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.